These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8791957)

  • 1. Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel disease.
    Collins CE; Benson MJ; Burnham WR; Rampton DS
    Aliment Pharmacol Ther; 1996 Jun; 10(3):315-20. PubMed ID: 8791957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ridogrel, a dual thromboxane synthase inhibitor and receptor antagonist: anti-inflammatory profile in inflammatory bowel disease.
    Carty E; Macey M; McCartney SA; Rampton DS
    Aliment Pharmacol Ther; 2000 Jun; 14(6):807-17. PubMed ID: 10848666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis.
    Casellas F; Papo M; Guarner F; Antolín M; Segura RM; Armengol JR; Malagelada JR
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):221-6. PubMed ID: 7743303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
    Szewczuk MR; Depew WT
    Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis.
    Lauritsen K; Laursen LS; Bukhave K; Rask-Madsen J
    Gastroenterology; 1988 Jul; 95(1):11-7. PubMed ID: 2836256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
    Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
    Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease.
    Schreiber S; Raedler A; Conn AR; Rombeau JL; MacDermott RP
    Gut; 1992 Feb; 33(2):236-41. PubMed ID: 1541420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease.
    Hillier K; Jewell R; Dorrell L; Smith CL
    Gut; 1991 Oct; 32(10):1151-5. PubMed ID: 1955170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease.
    Mahida YR; Lamming CE; Gallagher A; Hawthorne AB; Hawkey CJ
    Gut; 1991 Jan; 32(1):50-4. PubMed ID: 1846838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease.
    Babyatsky MW; Rossiter G; Podolsky DK
    Gastroenterology; 1996 Apr; 110(4):975-84. PubMed ID: 8613031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "In vitro" and "ex vivo" effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human platelets.
    Berrettini M; De Cunto M; Parise P; Grasselli S; Nenci GG
    Eur J Clin Pharmacol; 1990; 39(5):495-500. PubMed ID: 1963845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.
    Rachmilewitz D; Stamler JS; Bachwich D; Karmeli F; Ackerman Z; Podolsky DK
    Gut; 1995 May; 36(5):718-23. PubMed ID: 7541008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications.
    Adar T; Shteingart S; Ben-Ya'acov A; Shitrit AB; Livovsky DM; Shmorak S; Mahamid M; Melamud B; Vernea F; Goldin E
    Dig Dis Sci; 2016 Jul; 61(7):1915-24. PubMed ID: 26874691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines and platelet-activating factor in human inflamed colonic mucosa.
    Rachmilewitz D; Eliakim R; Simon P; Ligumsky M; Karmeli F
    Agents Actions; 1992; Spec No():C32-6. PubMed ID: 1359744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphation of colonic and rectal mucin in inflammatory bowel disease: reduced sulphation of rectal mucus in ulcerative colitis.
    Raouf AH; Tsai HH; Parker N; Hoffman J; Walker RJ; Rhodes JM
    Clin Sci (Lond); 1992 Nov; 83(5):623-6. PubMed ID: 1335401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imbalance of prostacyclin and thromboxane synthesis in Crohn's disease.
    Hawkey CJ; Karmeli F; Rachmilewitz D
    Gut; 1983 Oct; 24(10):881-5. PubMed ID: 6578172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostanoid synthesis by cultured peripheral blood mononuclear cells in inflammatory diseases of the bowel.
    Rachmilewitz D; Ligumsky M; Haimovitz A; Treves AJ
    Gastroenterology; 1982 Apr; 82(4):673-9. PubMed ID: 6949849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease.
    Kimura H; Miura S; Shigematsu T; Ohkubo N; Tsuzuki Y; Kurose I; Higuchi H; Akiba Y; Hokari R; Hirokawa M; Serizawa H; Ishii H
    Dig Dis Sci; 1997 May; 42(5):1047-54. PubMed ID: 9149061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
    Griga T; Voigt E; Gretzer B; Brasch F; May B
    Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.